Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Samsung Electronics vows to pay compensation for ill workers by 2028

Published 11/23/2018, 12:54 AM
Updated 11/23/2018, 12:54 AM
© Reuters. Samsung Electronics' co-chief executive Kim Ki-nam shakes hands with Hwang Sang-ki, founder of activist group Sharps and father of a dead chip factory worker with leukaemia, during an event in Seoul

By Heekyong Yang

SEOUL (Reuters) - South Korea's Samsung Electronics (KS:005930) on Friday vowed to compensate by 2028 its local chip and display factory workers who have suffered from work-related illnesses.

The move settles a year-long dispute between the world's top memory chipmaker and an advocacy group representing sickened workers and their families after the 2007 death of a Samsung chip factory worker with leukemia sparked concerns over working conditions at the South Korean company.

"Our effort was insufficient to better understand the pain affected workers and their families went through," Samsung Electronics Chief Executive Kim Ki-nam said in a public apology during an event to sign the agreement with the advocacy group.

Following the mediation panel's decision earlier this month on the case, Samsung will pay up to 150 million won ($132,649.45) for each former and current employee suffering from work-related diseases if they are found to be caused by exposure to harmful chemicals.

All former and current Samsung employees as well as the company's contractors who worked at Samsung's semiconductor and display production plants for more than one year since 1984 are eligible to be compensated for their illnesses.

Kim said the company would post its compensation guidelines along with an apology letter by at the end of this month on the company's website and an independent Seoul-based law firm will conduct the review process for affected workers for their compensation eligibility.

South Korean activist group Sharps claims around 200 workers have fallen ill after working at Samsung plants and 70 of them have died subsequently.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Hwang Sang-ki, founder of Sharps and father of a dead chip factory worker with leukemia, told Reuters that besides those 200 he expected more workers to apply for compensation, but it would take a long medical process to prove their diseases are directly related to the work environment.

Both Samsung and Sharps did not elaborate on the potential size of the total compensation.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.